Stem Cells May Move To The Front Line Against Multiple Sclerosis

Researchers maintain that patients with severe multiple sclerosis should be able to receive autologous hematopoietic stem cell transplantation as a first-line therapy.

To read more about the article, click the following link:

Stem Cells May Move to the Front Line against Multiple Sclerosis